Yesterday, the Project on Government Oversight (POGO), an independent, non-partisan investigative organization, sent a letter to FDA Commissioner Margaret Hamburg detailing the multiple conflicts of interest among certain members of the recent FDA advisory committee that …
Read the full story »Yesterday, the Project on Government Oversight (POGO), an independent, non-partisan investigative organization, sent a letter to FDA Commissioner Margaret Hamburg detailing the multiple conflicts of interest among certain members of the recent FDA advisory committee that found in a close vote the benefits of Yaz and Yasmin outweighed the risk of developing fatal blood clots. Read the full story »
The Wall Street Journal reported today that three doctors who served on a Food and Drug Administration advisory panel that in December examined the safety of newer generation birth control pills, including Yaz and Yasmin …
January 11, 2012 Update
The close vote of the FDA advisory committee that the benefits of Yaz and Yasmin outweighed the potential health risks has received substantial media attention after it was revealed that several of …
Joan Cummins testified today at a Food and Drug Administration (FDA) advisory committee on the safety of newer birth control pills, including Yaz and Yasmin, which contain drospirenone. In September 2010, Cummins’ daughter Michelle Pfleger …
The Food and Drug Administration (FDA) is considering whether the birth control drug Yaz should come in packaging that warns consumers of an increased risk of side effects including blood clots. The FDA will hold …
Bloomberg reports that in a document unsealed yesterday in federal court, David Kessler, commissioner of the Food and Drug Administration (FDA) under President Bush, states that Bayer withheld data showing that Yasmin increases the risk …
As reported in Bloomberg, newly released evidence shows that Bayer Corporation may have actively promoted off-label usage of its Yaz birth control pill.
Units of Bayer AG (BAYN), Germany’s largest drugmaker, may have sought to market …
The American Association for Justice will be holding a teleseminar on November 10, 2011 on Yaz and Yasmin litigation, in response to a new FDA -sponsored study released on October 27, 2011, finding that women taking Yasmin had a 75 percent greater chance of developing a dangerous blood clot than women taking older birth control drugs.
In an FDA report published Thursday, October 27, 2011, U.S. regulators warn that blood-clot risks may be tied to Bayer birth control pills.
ABC’s chief law and justice correspondent, Chris Cuomo, interviews Carissa Ubersox, a former pediatric nurse who started taking Bayer’s Yaz birth control pills when she wanted to look her best for her wedding and “saw commercials suggesting help with bloating and acne.”
Last week the Food and Drug Administration expressed concern that Bayer’s birth control drugs Yaz and Yasmin can raise the risk of patients developing blood clots above earlier generation oral contraceptives.
Attorney Wendy Fleishman Discusses the Risks Associated with the Use of Yaz, Yasmin and Ocella
Attorney Wendy Fleishman Provides an Update on Yaz, Yasmin and Ocella Dangers
CNN Senior Medical Correspondent on What To Do If You Are Concerned About Your Yaz Birth Control
ABC Discusses Upcoming FDA Hearing on Whether Yaz Packaging Should Include Extra Blood Clot Warning
Interview with Mother Whose Daughter Leah Mayfield Died After Taking Birth Control Pills
Interview with Mother Whose Daughter Michelle Pfleger Died From Blood Clot Allegedly Caused by Yaz
